18F-FDG PET /CT for Monitoring of Treatment Response in Breast Cancer | ||
| Benha Medical Journal | ||
| Articles in Press, Accepted Manuscript, Available Online from 01 February 2025 PDF (304.07 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/bmfj.2025.343907.2283 | ||
| Authors | ||
| Asmaa Abdel Monem Ghalwash* 1; Tamer Ahmed Kamal2; Rasha Mahmoud Dawoud3; Ahmed Said Mohamed4 | ||
| 1M.B.B. Ch M.Sc. Of Radiodiagnosis, Tanta University | ||
| 2Professor of diagnostic and interventional radiology Faculty of Medicine - Benha University | ||
| 3Professor of diagnostic radiology Faculty of Medicine - Tanta University | ||
| 4Lecturer of diagnostic radiology Faculty of Medicine - Benha University | ||
| Abstract | ||
| Background: Positron emission tomography (PET), with or without integrated computed tomography (CT), using 18F-Fluorodeoxyglucose (FDG) is based on the principle of increased glucose metabolism in malignant tumors and has been investigated frequently in breast cancer (BC). The aim of this work was to evaluate the potential role of 18F-FDG PET/CT in monitoring treatment of BC and assessment of recurrence after surgical or systemic treatment. Methods: This current study was carried out on 50 female patients aged from 24 to 73 years old, diagnosed with BC undergoing neoadjuvant chemotherapy, radio, hormonal or surgical treatment. All patients were subjected to 18F-FDG and PET /CT evaluation. Results: Detection of lesions by 18F-FDG PET /CT was positive in 37 (74%) patients. Local recurrence occurred in 7 (14%) patients. Distance metastasis occurred in brain in 1 (2%) patient, lymph node in 6 (12%) patients, liver in 6 (12%) patients, lung in 5 (10%) patients and bone in 7 (14%) patients. local recurrence and distance metastasis occurred in 5 (10%) patients. Distance metastasis occurred in brain in 1 (2%) patient, lymph node in 2 (4%) patients, liver in 5 (10%) patients, lung in 4 (8%) patients and bone in 6 (12%) patients. Progression occurred in 22 (44%) patients. Regression occurred in 13 (26%) patients. Stationary occurred in 3 (6%) patients. Conclusions: Whole body FDG-PET/CT must be considered a useful and golden tool in monitoring treatment of BC allowing an identification of the local recurrence of the BC and distance metastasis. | ||
| Keywords | ||
| 18F- Fluorodeoxyglucose; Positron Emission Tomography; Computed Tomography; Breast Cancer; Metastasis | ||
|
Statistics Article View: 47 PDF Download: 28 |
||
